GRN and frontotemporal dementia: SAHA (Vorinostat), a histone deacetylase inhibitor, was identified as a small molecule enhancer of GRN, increasing GRN gene and PGRN protein expressions in cultured cells and patient-derived cells with GRN haploinsufficiency, though it was not yet approved for FTD clinical trials [93].